40.3 🩺 內科專科考前版

40.3.0.1 📌 䞀頁重點

  • 22Erefractory chronic cough therapygefapixant P2X3 antagonist
  • Cough hypersensitivity syndrome 認可
  • Bronchiectasis 越䟆越識別
  • Taiwan ACEI cough 高比䟋

40.3.0.2 💊 進階治療

40.3.0.2.1 Refractory Chronic Cough
  • Gabapentin / pregabalin
  • Amitriptyline
  • Gefapixant (P2X3 antagonist) — 22E new
  • Speech pathology / cough suppression therapy
40.3.0.2.2 Bronchiectasis
  • Treat exacerbation: antibiotic
  • Mucolytic
  • Airway clearance
  • Inhaled antibiotic for chronic Pseudomonas
40.3.0.2.3 Eosinophilic Bronchitis
  • ICS 有效

40.3.0.3 🌟 Pearls (8)

  1. Refractory cough P2X3 antagonist
  2. NTM (nontuberculous mycobacteria) in elderly + chronic cough + bronchiectasis
  3. Pertussis 成人 atypical → 衛教 contacts
  4. CT chest for unexplained chronic cough
  5. Hyposensitive cough: GBS, paraneoplastic
  6. Cough-variant asthma 對 ICS 反應
  7. GERD cough 䞍䞀定有 heartburn
  8. Smoker chronic cough → CXR + LDCT screen

40.3.0.4 📍 台灣 Context

  • ACEI cough 圚台灣比䟋高郚分 genetic
  • Bronchiectasis post-TB åžž
  • LDCT 健保 lung cancer screening
  • 䞭醫止咳 甚藥

40.3.0.5 🎓 內專重點

  1. 䞉分類
  2. Chronic 3 å·šé ­
  3. Refractory cough22E new
  4. Pertussis adult
  5. Red flags → cancer/TB/bronchiectasis

⚠ AI 草皿。